TABLE 5.
Line | Anisotropy values | % drug accumulationb |
|||
---|---|---|---|---|---|
AmB | MIL | PMM | SbIII | ||
WTM | 0.220 ± 0.010 | 100 ± 7.23 | 100 ± 8.43 | 100 ± 7.43 | 100 ± 1.06 |
A | 0.290 ± 0.001** | 100.28 ± 0.69 | |||
M | 0.230 ± 0.028 | 101.01 ± 4.42 | |||
P | 0.251 ± 0.001* | 86.05 ± 7.80 | |||
S | 0.244 ± 0.003* | 109.48 ± 11.52 | |||
AS | 0.246 ± 0.003* | 100.25 ± 0.54 | 233.23 ± 11.79*** | ||
SP | 0.266 ± 0.001* | 91.47 ± 9.48 | 145.42 ± 8.22*** |
Steady-state fluorescence anisotropy of DPH was incorporated in plasma membranes of different Leishmania lines. The drug accumulation assay was performed after incubating Leishmania lines with 0.1 μM AmB, 2.5 μM MIL, 10 μM PMM, or 100 μM SbIII, as described in Materials and Methods. Significant differences versus WTM line were determined by Student's t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
The data are the means ± SD from three independent experiments.